|
|
 Previous Article | Table of Contents | Next Article 
Mitogenic Responses Mediated Through the Proteinase-Activated Receptor-2 Are Induced by Expressed Forms of Mast Cell  - or  -Tryptases
Humayun Mirza,
Valentina A. Schmidt,
Claudia K. Derian,
Jolyon Jesty, and
Wadie F. Bahou
From the Department of Medicine, State University of New York at Stony Brook, Stony Brook, NY; and the R.W. Johnson Pharmaceutical Research Institute, Springhouse, PA.
The proteinase-activated receptor-2 (PAR-2) is the second member of a putative larger class of proteolytically activated receptors that mediate cell activation events by receptor cleavage or synthetic peptidomimetics corresponding to the newly generated N-terminus. To further study the previously identified mitogenic effects of PAR-2, we used the interleukin-3 (IL-3)-dependent murine lymphoid cell line, BaF3, for generation of stable cell lines expressing PAR-2 (BaF3/PAR-2) or the noncleavable PAR-2 mutant PAR-2Arg36  Ala36. Only BaF3 cells expressing either wild-type or mutated receptor exhibited mitogenic responses when grown in IL-3-deficient media supplemented with PAR-2 activating peptide (SLIGRL, PAR39-44). This effect was dose dependent with an EC50 of ~80 µmol/L, sustained at 24, 48, and 72 hours, and was also demonstrable using thrombin receptor peptide TR42-47. Because tryptase shares ~70% homology with trypsin (previously shown to activate PAR-2), we studied recombinantly expressed forms of  - and  -tryptases as candidate protease agonists for PAR-2. Hydrolytic activity of the chromogenic substrate tosyl-glycyl-prolyl-argly-4-nitroanilide acetate was present as a sharp peak at Mr ~130, confirming the presence of secretable and functionally active homotetrameric - and -tryptases in transfected COS-1 cells. Dose-dependent proliferative responses were evident using either secreted form of tryptase with maximal responses seen at ~3 pmol/L (0.1 U/L). Receptor proteolysis was necessary and sufficient for mitogenesis because active site-blocked tryptase failed to induce this response, and proliferative responses were abrogated in BaF3 cells expressing PAR-2Arg36 Ala36. These results specifically identify both forms of mast cell tryptases as serine protease agonists for PAR-2 and have implications for elucidating molecular mechanisms regulating cellular activation events mediated by proteases generated during inflammatory, fibrinolytic, or hemostatic-regulated pathways.
Blood, Vol. 90 No. 10 (November 15), 1997:
pp. 3914-3922
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J Wang and M Hauer-Jensen
Neuroimmune interactions: potential target for mitigating or treating intestinal radiation injury
Br. J. Radiol.,
September 1, 2007;
80(Special_Issue_1):
S41 - S48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Seitz, S. Hess, H. Schulz, R. Eckl, G. Busch, H. P. Montens, R. Brandl, S. Seidl, A. Schomig, and I. Ott
Membrane-Type Serine Protease-1/Matriptase Induces Interleukin-6 and -8 in Endothelial Cells by Activation of Protease-Activated Receptor-2: Potential Implications in Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2007;
27(4):
769 - 775.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Oikonomopoulou, K. K. Hansen, M. Saifeddine, I. Tea, M. Blaber, S. I. Blaber, I. Scarisbrick, P. Andrade-Gordon, G. S. Cottrell, N. W. Bunnett, et al.
Proteinase-activated Receptors, Targets for Kallikrein Signaling
J. Biol. Chem.,
October 27, 2006;
281(43):
32095 - 32112.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. S. OSSOVSKAYA and N. W. BUNNETT
Protease-Activated Receptors: Contribution to Physiology and Disease
Physiol Rev,
April 1, 2004;
84(2):
579 - 621.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Weidinger, A. Mayerhofer, M.B. Frungieri, V. Meineke, J. Ring, and F.M. Kohn
Mast cell-sperm interaction: evidence for tryptase and proteinase-activated receptors in the regulation of sperm motility
Hum. Reprod.,
December 1, 2003;
18(12):
2519 - 2524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Maree and D. Fitzgerald
PAR2 Is Partout and Now in the Heart
Circ. Res.,
March 8, 2002;
90(4):
366 - 368.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Chambers, J. L. Black, P. Poronnik, and P. R. A. Johnson
Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle
Am J Physiol Lung Cell Mol Physiol,
December 1, 2001;
281(6):
L1369 - L1378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Berger, D.-W. Perng, H. Thabrew, S. J. Compton, J. A Cairns, A. R. McEuen, R. Marthan, J.-M. Tunon De Lara, and A. F. Walls
Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells
J Appl Physiol,
September 1, 2001;
91(3):
1372 - 1379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Buresi, E. Schleihauf, N. Vergnolle, A. Buret, J. L. Wallace, M. D. Hollenberg, and W. K. MacNaughton
Protease-activated receptor-1 stimulates Ca2+-dependent Cl{-} secretion in human intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol,
August 1, 2001;
281(2):
G323 - G332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. KONDO, S. KAGAMI, H. KIDO, F. STRUTZ, G. A. MULLER, and Y. KURODA
Role of Mast Cell Tryptase in Renal Interstitial Fibrosis
J. Am. Soc. Nephrol.,
August 1, 2001;
12(8):
1668 - 1676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin
Proteinase-Activated Receptors
Pharmacol. Rev.,
June 1, 2001;
53(2):
245 - 282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. A. Akers, M. Parsons, M. R. Hill, M. D. Hollenberg, S. Sanjar, G. J. Laurent, and R. J. McAnulty
Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2
Am J Physiol Lung Cell Mol Physiol,
January 1, 2000;
278(1):
L193 - L201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Al-Ani, M. Saifeddine, A. Kawabata, B. Renaux, S. Mokashi, and M. D. Hollenberg
Proteinase-Activated Receptor 2 (PAR2): Development of a Ligand-Binding Assay Correlating with Activation of PAR2 by PAR1- and PAR2-Derived Peptide Ligands
J. Pharmacol. Exp. Ther.,
August 1, 1999;
290(2):
753 - 760.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. Huang, L. Li, S. A. Krilis, K. Chanasyk, Y. Tang, Z. Li, J. E. Hunt, and R. L. Stevens
Human Tryptases alpha and beta /II Are Functionally Distinct Due, in Part, to a Single Amino Acid Difference in One of the Surface Loops That Forms the Substrate-binding Cleft
J. Biol. Chem.,
July 9, 1999;
274(28):
19670 - 19676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Dery, M. S. Thoma, H. Wong, E. F. Grady, and N. W. Bunnett
Trafficking of Proteinase-activated Receptor-2 and beta -Arrestin-1 Tagged with Green Fluorescent Protein. beta -ARRESTIN-DEPENDENT ENDOCYTOSIS OF A PROTEINASE RECEPTOR
J. Biol. Chem.,
June 25, 1999;
274(26):
18524 - 18535.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. P. Damiano, W.-M. Cheung, R. J. Santulli, W.-P. Fung-Leung, K. Ngo, R. D. Ye, A. L. Darrow, C. K. Derian, L. de Garavilla, and P. Andrade-Gordon
Cardiovascular Responses Mediated by Protease-Activated Receptor-2 (PAR-2) and Thrombin Receptor (PAR-1) are Distinguished in Mice Deficient in PAR-2 or PAR-1
J. Pharmacol. Exp. Ther.,
February 1, 1999;
288(2):
671 - 678.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
L. Li, Y. Li, S. W. Reddel, M. Cherrian, D. S. Friend, R. L. Stevens, and S. A. Krilis
Identification of Basophilic Cells that Express Mast Cell Granule Proteases in the Peripheral Blood of Asthma, Allergy, and Drug-Reactive Patients
J. Immunol.,
November 1, 1998;
161(9):
5079 - 5086.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. A. Schmidt, W. C. Nierman, D. R. Maglott, L. D. Cupit, K. A. Moskowitz, J. A. Wainer, and W. F. Bahou
The Human Proteinase-activated Receptor-3 (PAR-3) Gene. IDENTIFICATION WITHIN A PAR GENE CLUSTER AND CHARACTERIZATION IN VASCULAR ENDOTHELIAL CELLS AND PLATELETS
J. Biol. Chem.,
June 12, 1998;
273(24):
15061 - 15068.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Molino, P. N. Raghunath, A. Kuo, M. Ahuja, J. A. Hoxie, L. F. Brass, and E. S. Barnathan
Differential Expression of Functional Protease-Activated Receptor-2 (PAR-2) in Human Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol.,
May 1, 1998;
18(5):
825 - 832.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Compton, J. A. Cairns, K.-J. Palmer, B. Al-Ani, M. D. Hollenberg, and A. F. Walls
A Polymorphic Protease-activated Receptor 2 (PAR2) Displaying Reduced Sensitivity to Trypsin and Differential Responses to PAR Agonists
J. Biol. Chem.,
December 8, 2000;
275(50):
39207 - 39212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Huang, G. T. De Sanctis, P. J. O'Brien, J. P. Mizgerd, D. S. Friend, J. M. Drazen, L. F. Brass, and R. L. Stevens
Evaluation of the Substrate Specificity of Human Mast Cell Tryptase beta I and Demonstration of Its Importance in Bacterial Infections of the Lung
J. Biol. Chem.,
July 6, 2001;
276(28):
26276 - 26284.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
